Q2 2025 Earnings Call Transcript February 12, 2025 ReposiTrak, Inc. misses on earnings expectations. Reported EPS is $0.08 EPS, expectations were $0.09. Operator: Greetings, and welcome to the ...
A new study argues that data centers could be ideal demand-response participants because they have the potential to be ...
31m
Company reported positive Phase 2b QUALITY study topline results for enobosarm + semaglutide (Wegovy®) with study meeting prespecified primary endpoint of preservation of lean mass as well as greater ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback